Liftstream is an executive search recruitment company in the life sciences sector

Nominations Committees’ Resolutions Series: #1- Board and Executive Succession Planning Must Be Forward Looking

Posted on January 25, 2016 by admin

Succession Planning should concern the nomination committee all year round, but the ticking over of the calendar is the perfect opportunity to appraise the sophistication of your succession planning.

Read the full article…

Posted in Corporate Governance | Tagged biotech, Biotech IPOs, board refreshment, Bob Hugin, celgene, corporate governance, Harald Stock, Howard Schiller, JP Morgan Healthcare 2016, London Stock Exchange, Mark Alles, Massachusetts, Michelle Dipp, nomination committees, Ovascience, succession planning, Valeant | Leave a comment

Third Rock Ventures Recruits Industry Heavyweight Michael Bonney

Posted on January 7, 2016 by admin

Boston based venture capital powerhouse Third Rock Ventures, have announced the appointment of Michael W. Bonney as partner. Mr. Bonney was previously the CEO of Cubist Pharmaceuticals until its acquisition by Merck & Co. Mr. Bonney brings to Third Rock extensive operational, commercial, and senior management expertise in the biopharmaceutical industry. Prior to serving as the CEO of Cubist from June 2003 until December 2014, Mike served as president and chief operating officer of the company, joining in 2002. From 1995 to 2001, he held various positions of increasing responsibility at Biogen, including vice president, sales and marketing. Prior to joining Biogen, he held positions in sales, marketing, and strategic planning at Zeneca Pharmaceuticals, concluding his 11-year career there as national business director. He currently also serves as a board director of two significant biotech companies, Celgene and Alnylam.Watch Full Movie Online Streaming Online and Download

Read the full article…

Posted in Executive Appointments | Tagged #BoardStep, Alnylam, Boston Biotech, celgene, Cubist, Diversifying the Outlook: The X&Y of Biotechnology Leadership., executive appointment, Kevin Starr, Michael Bonney, Stepping Up to the C-suite and Board, Third Rock Ventures | Leave a comment

Codiak BioSciences Begins to Appoint Executives to Leadership Team

Posted on January 7, 2016 by admin

Codiak BioSciences, a venture-backed start-up in Cambridge, Mass, has appointed Ariel Jasie as Chief Business Officer, Linda Bain as CFO and Konstantin Konstantinov as Senior Vice President.

Read the full article…

Posted in Executive Appointments | Tagged #InvestinBioMgt, Ariel Jasie, biogen, Bluebirdbio, Boston Biotech, Cambridge Massachucetts, celgene, CFO, Codiak Biosciences, Doug Williams, executive appointment, Flagship Ventures, Linda Bain, women executives | Leave a comment

Women Executives: Stepping Up to the C-suite and Board (Event Schedule)

Posted on November 7, 2015 by admin

Event Date:
Thursday, December 3, 2015 from 4:00 PM to 7:30 PM (EST)
Event Location:
Biogen, Bio-9 Building, 300 Binney Street Cambridge, MA 02142 – View Map

Read the full article…

Posted in Board Director Appointments, Corporate Governance, Workplace Diversity | Tagged #BoardStep, Alnylan Pharmaceuticals, Atlas Venture, biogen, board director, Broad Institute, Bruce Booth, celgene, CEO, Gwen Acton, Ironwood, J&J Innovation, Jodie Morrison, Karl Simpson, Luc Therapeutics, Marian Nakada, Marsha Fanucci, Mary Thistle, Michael Bonney, Nimbus Therapeutics, Paula Ragan, Pauline Jen Ryan, Professor Susan Adams, Rosana Kapeller, Samantha Singer, Susan Alexander, Tokai, Tokai Pharmaceuticals, Vanessa King, X4 Pharmaceuticals | Leave a comment

Board Appointment for IPO-ready Dimension Therapeutics

Posted on October 20, 2015 by admin

Just days after setting the terms for its pending IPO, Dimension Therapeutics, Inc., a leading rare disease company advancing novel, liver-directed treatments for diverse genetic disorders, announced the election of Alan B. Colowick, M.D., M.P.H., Executive Vice President of Celgene Corporation, to Dimension’s Board of Directors. Dr. Colowick brings strong operational expertise and more than 15 years of experience in biopharmaceutical development. His election to the company’s Board is effective immediately.

Read the full article…

Posted in Board Director Appointments | Tagged Alan Colowick, Annalisa jenkins, Bay Area Cluster, board appointment, Board of Directors, Boston Biotech, celgene, CEO, Dimension Therapeutics, Gene therapy, Harvard, rare diseases | Leave a comment

Celgene Board Diversifies Above Key 30% Mark

Posted on October 19, 2015 by admin

Celgene has announced the appointment of Julia Haller, M.D, to the Board of Directors. The appointment means Celgene now has three females on the board and reaches a 33% ratio of women non-executive board directors, a critical mass that is likely to drive a significant advantage for the way in which Celgene is governed and also contribute to a sustainable level of diversity. With strong advocates for gender diversity on its board, such as Michael Bonney and Richard Barker, Celgene is showing that it is very much possible to create a gender diverse board of directors in biotechnology.

Read the full article…

Posted in Board Director Appointments, Workplace Diversity | Tagged #InvestinBioMgt, 30% Club, board diversity, Board of Directors, Boston Biotech, celgene, Michael Bonney, Richard Barker, women on boards | Leave a comment

Biotech M&A Continues to Climb the Curve

Posted on July 15, 2015 by admin

The trajectory of biotech M&A has been steep in 2015, so the $7.2bn acquisition of Receptos by oncology powerhouse Celgene, increases the gradient even further. This deal came out of left field, especially as commentators were still raking over the sizable partnering deal Celgene has just cemented with Juno Therapeutics in immuno-oncology.

Read the full article…